no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Diagnosis and management of locally advanced disease
|
Williams, Scott |
|
2015 |
|
S |
p. S10-S11 2 p. |
article |
2 |
Emerging perspectives in prostate cancer: Insights from the 4th Asia Pacific Prostate Cancer Conference
|
Mainwaring, Paul |
|
2015 |
|
S |
p. S1-S4 4 p. |
article |
3 |
Epidemiology of prostate cancer in Asia
|
Chiong, Edmund |
|
2015 |
|
S |
p. S9- 1 p. |
article |
4 |
Highlights from the Charité Berlin Prostate Cancer Preceptorships
|
Voravud, Narin |
|
2015 |
|
S |
p. S13- 1 p. |
article |
5 |
Management of elderly mCRPC patients
|
Ozono, Seiichiro |
|
2015 |
|
S |
p. S24-S25 2 p. |
article |
6 |
Management of locally advanced prostate cancer before the era of abiraterone/enzalutamide: A case study from India
|
Rawal, Sudhir |
|
2015 |
|
S |
p. S20-S21 2 p. |
article |
7 |
Managing advanced prostate cancer: Focus on the patient
|
Williams, Scott |
|
2015 |
|
S |
p. S18-S19 2 p. |
article |
8 |
Role of radical localised treatment in patients with metastatic prostate cancer
|
Zhou, LiQun |
|
2015 |
|
S |
p. S12- 1 p. |
article |
9 |
The healthcare economics of medication for prostate cancer
|
Horie, Shigeo |
|
2015 |
|
S |
p. S7-S8 2 p. |
article |
10 |
The molecular pathology of Castrate Resistant Prostate Cancer (CRPC)
|
Mainwaring, Paul |
|
2015 |
|
S |
p. S5-S6 2 p. |
article |
11 |
The role of chemohormonal therapy in metastatic hormone sensitive prostate cancer
|
Kanesvaran, Ravindran |
|
2015 |
|
S |
p. S16-S17 2 p. |
article |
12 |
Upon failure of first-line ADT, should second-line hormonal manipulation without survival benefit data still be used?
|
Lojanapiwat, Bannakij |
|
2015 |
|
S |
p. S14-S15 2 p. |
article |
13 |
Use of biomarkers in CRPC and future treatment in Asia
|
Mainwaring, Paul |
|
2015 |
|
S |
p. S26-S27 2 p. |
article |
14 |
Withdrawal syndrome and PSA flare in the management of mCRPC with abiraterone
|
Chiang, Po Hui |
|
2015 |
|
S |
p. S22-S23 2 p. |
article |